• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec12
Arcus Biosciences Inc. Refocuses R&D on HIF-2a Inhibitor Casdatifan
13:30
Gilead Sciences and Arcus Biosciences halt phase III trial for gastric and esophageal cancer drugs
13:23
Nov29
BofA Raises Arcus Biosciences Target to $26.00
17:26
Nov18
Arcus Biosciences Inc. Participates in the 8th Evercore ISI Healthcare Conference
21:05
Oct31
Arcus Biosciences to Offer Shares at $18.25 per Share in Public Offering
03:36
Oct30
Citigroup Raises Arcus Biosciences Target Price to $56
20:08

Schedules & Filings

Schedules
Filings
Oct28
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 26 M, Net Income -135 M, EPS -1.2676

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 160 M

May6
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 28 M, Net Income -112 M, EPS -1.1382

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More